ORLY
48
-2
PYPL
52
3
CRM
59
-5
DVN
46
2
SLG
39
9
XYL
41
-6
HIG
50
-2
R
76
5
SIG
44
3
GD
57
-3
FITB
73
-2
LMT
50
3
PBI
40
-2
CMG
51
-2
AVY
50
3
NEE
68
11
WY
39
2
EMN
55
3
NWS
46
-12
RL
83
7
ORLY
48
-2
PYPL
52
3
CRM
59
-5
DVN
46
2
SLG
39
9
XYL
41
-6
HIG
50
-2
R
76
5
SIG
44
3
GD
57
-3
FITB
73
-2
LMT
50
3
PBI
40
-2
CMG
51
-2
AVY
50
3
NEE
68
11
WY
39
2
EMN
55
3
NWS
46
-12
RL
83
7
Financhill
Back

Cipher Pharmaceuticals, Inc. 10K Form

Buy
63

CPHRF
Cipher Pharmaceuticals, Inc.

Last Price:
$10.58
Seasonality Move:
-6.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPHRF News And Ratings

See the #1 stock for the next 7 days that we like better than CPHRF

CPHRF Financial Statistics

Sales & Book Value

Annual Sales: $33.4M
Cash Flow: $10.8M
Price / Cash Flow: 9.22
Annual Sales: $4.49
Price / Book: 2.36

Profitability

EPS (TTM): 0.66980
Net Income (TTM): $17.4M
Gross Margin: $20.1M
Return on Equity: 16.39%
Return on Assets: 11.14%

Cipher Pharmaceuticals, Inc. Earnings Forecast

Key Cipher Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 18 years for CPHRF is 60.20%.
  • The Selling, General & Administrative Expenses for CPHRF have been equal to 44.82% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of CPHRF is 34.60% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 12 years.

Cipher Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CPHRF
Website: cipherpharma.com

Debt

Debt-to-Equity Ratio: 0.12
Current Ratio: 1.31
Quick Ratio: 0.91

Price-to-Earnings

Trailing P/E Ratio: 23.12
Forward P/E Ratio: 0

CPHRF Technical Analysis vs Fundamental Analysis

Buy
63
Cipher Pharmaceuticals, Inc. (CPHRF) is a Buy

Is Cipher Pharmaceuticals, Inc. a Buy or a Sell?